Unanswered questions in screening for prostate cancer
Authors:
- D.E NealDND.E Neal
- H.Y LeungHLH.Y Leung
- P.H PowellPPP.H Powell
- F.C HamdyFHF.C Hamdy
- J.L DonovanJDJ.L Donovan
- 1 June 2000
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 36 (10) , 1316-1321
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General PopulationJournal of Urology, 1997
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Should we screen for prostate cancer?BMJ, 1997
- Screening could seriously damage your healthBMJ, 1997
- Breast and prostate cancer in the relatives of men with prostate cancerBritish Journal of Urology, 1996
- Localised prostatic cancer: management and detection issuesThe Lancet, 1994
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993
- A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research TeamArchives of Family Medicine, 1993
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990